Skip to main content
OpenTrials

Clinical trial condition

Lymphoproliferative Disorders

Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,146 public trials 2,034 recruiting studies
Refine in advanced search Browse all conditions

Lymphoproliferative Disorders trial results

Recruiting

Elranatamab/Lenalidomide Consolidation and/or Elranatamab Maintenance Versus Standard of Care After D-VRd Induction in Transplant-eligible NDMM Patients

NCT06918002

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations
  • CHU Amiens Amiens, France
  • CHU Angers Angers, France
  • Ch Annecy Genevois Annecy, France
  • Centre Hospitalier d'Argenteuil Victor Dupouy Argenteuil, France
View all 64 locations
View Trial Details
Recruiting

Delayed Toxicities Post-CAR-T

NCT07665307

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Chemically-Induced Disorders, +16 more
Locations
  • UCSF Medical Center San Francisco, California, United States
  • Mount Sinai New York, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
View Trial Details
Recruiting

CD45BE-HSPC + CART-45 Cells

NCT07451054

Conditions
B-Cell Non-Hodgkin Lymphoma (NHL), Hemic and Lymphatic Diseases, Hodgkin Disease, +13 more
Locations
  • University of Pennsylvania Philadelphia, Pennsylvania, United States
View Trial Details
Recruiting

Phase Ib/II Study Assessing the Clinical Activity and Safety of Brexucabtagene Autoleucel as a Consolidation in Patients With Relapsed/Refractory (R/R) and Newly Diagnosed B-cell Acute Lymphocytic Leukemia (ALL) Post Cytoreduction With Mini-HCVD-inotuzumab-blinatumomab/HCVAD-inotuzumab-blinatumomab

NCT06287229

Conditions
B-cell Acute Lymphocytic Leukemia, Burkitt Lymphoma, DNA Virus Infections, +20 more
Locations
  • MD Anderson Cancer Center Houston, Texas, United States
View Trial Details
Recruiting

A Study to Investigate the Safety of Novel Dose Ramp-up Schedule(s) When Initiating Sonrotoclax in Participants Treated for Blood Cancers.

NCT06697184

Conditions
CLL, Chronic Disease, Chronic Lymphocytic Leukemia, +22 more
Locations
  • Moffitt Cancer Center Tampa, Florida, United States
  • Fort Wayne Medical Oncology and Hematology Fort Wayne, Indiana, United States
  • The University of Kansas Cancer Center Westwood, Kansas, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
View all 17 locations
View Trial Details

Related conditions